A community for China's biotech and pharmaceutical industries.

The biotech and pharmaceutical industries are taking priority in China. Recent changes to safety regulations and a general reorganization have increased BioChina’s productivity and influence in the life sciences. With a large scientific community, BioChina has appealed to foreign biotech companies, which now have a strong presence within the country and in the global market. China’s strong economy and dedication to the life sciences is expected to contribute to a thriving biotech industry now and in the future.

Sponsor
Pfizer


Hotbed News
Top 10 Countries For Diabetes Clinical Research Friday, November 21, 2014
Nanyang Technological University Engineers Develop Innovative Process To Print Flexible Electronic Circuits Monday, November 17, 2014
How A "Sock And Sandal Wearing Academic" Is Reviving Medical Device Maker USCOM Friday, November 14, 2014
BeiGene Co.,Ltd Bags $75 Million Friday, November 14, 2014
Brew For Your Heart: Tea Helps Lower Blood Pressure, Chinese Academy Of Medical Sciences And Peking Union Medical College Study Tuesday, November 04, 2014
The Growing Presence Of Biotech In The World Of Social Media Friday, November 21, 2014
When Will Biosimilars Impact The U.S. Market? Friday, October 31, 2014
Off With Their Heads! BioSpace's Favorite CEOs Who Got The Axe In 2014 Tuesday, November 04, 2014
BioPharm Executive: 5 Reasons To Hate Biotech Wednesday, November 05, 2014
Luye Pharma Pays $390 Million For Remaining 42% Of Beijing Jialin Pharma Tuesday, October 28, 2014
12345678910